Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation. This evidence concerns the gene ZUP1 and chronic myelogenous leukemia, BCR-ABL1 positive.